Prolapse, Vaginal Clinical Trial
— TAPPOfficial title:
Vaginal Native Tissues Repair for Pelvic Organ Prolapse
Verified date | August 2023 |
Source | University Hospital, Limoges |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The aim of the study is to assess at one year the effectiveness of the vaginal patch plastron in comparison of the anterior colporraphy through a combined definition of success: anatomic and functional.
Status | Recruiting |
Enrollment | 214 |
Est. completion date | March 27, 2028 |
Est. primary completion date | September 27, 2025 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 50 Years and older |
Eligibility | Inclusion Criteria: - Patient at 50 years of age or older - Symptomatic primary prolapse of the anterior vaginal wall defined by Aa and/or Ba points =0 according to the POP-Q system - A positive response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the PFDI-20) - Able to give informed consent - Performans Status score = 2 Exclusion Criteria: - Patient with need for surgical treatment for myorraphy of levator ani muscles - Patient with previous surgical cystocele repair. - Patient with evolving gynaecologic cancer. - Pregnancy or wish for future pregnancy, lactating woman. - Inability to participate in study follow-up or to provide informed consent. - Lack of social insurance . |
Country | Name | City | State |
---|---|---|---|
France | CHU de Bordeaux | Bordeaux | |
France | CH de Brive | Brive-la-Gaillarde | |
France | CHU de Clermont Ferrand | Clermont-Ferrand | |
France | CH de Gueret | Guéret | |
France | CHU de Limoges | Limoges | |
France | CHU de Saint-Etienne | Saint-Étienne | |
France | CHU de Toulouse - Paule de Viguier | Toulouse | |
France | CHU de Toulouse - Rangueil | Toulouse | |
France | CH de Tulle | Tulle |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Limoges |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rate of the prolapse surgery | The success rate of the prolapse surgery defined by a composite of objective and subjective measures:
Anatomic success defined by Aa and Ba values <0 in Pelvic Organ Prolapse Quantification System (POP-Q) AND Subjective success through reliable condition-specific quality-of-life questionnaires: A negative response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the Pelvic Floor Distress Inventory (PFDI-20)) AND Range score of Patient Global Impression of Improvement (PGI-I) 1 or 2 AND No need for other treatment for prolapse (surgical nor medical) |
1 year | |
Secondary | Rate of the prolapse surgery | The failure rate of the prolapse surgery defined by a composite of objective and subjective measures:
Recurrent prolapse defined by Aa and/or Ba values > or= 0 in POP-Q OR Subjective failure through reliable condition-specific quality-of-life questionnaires: A positive response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the PFDI-20) OR A PGI-I score > 2 OR Need of a new treatment for prolapse (surgical or medical) |
1 year | |
Secondary | Rate of post-operative complications | Rate of post-operative complications according to the Clavien-Dindo classification 45 days after the surgery by the patient's surgeon (not blinded) | 45 Days | |
Secondary | Sexual function | The sexual function improvement will be evaluated by the difference in PISQ 12 score (condition-specific quality-of-life questionnaire) between the inclusion and one year after the surgery for sexually active women | 1 year | |
Secondary | Rate of the prolapse surgery | The failure rate of the prolapse surgery defined by a composite of objective and subjective measures:
Recurrent prolapse defined by Aa and/or Ba values > or= 0 in POP-Q OR Subjective failure through reliable condition-specific quality-of-life questionnaires: A positive response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the PFDI-20) OR A PGI-I score > 2 OR Need of a new treatment for prolapse (surgical or medical) |
2 years | |
Secondary | Rate of the prolapse surgery | The failure rate of the prolapse surgery defined by a composite of objective and subjective measures:
Recurrent prolapse defined by Aa and/or Ba values > or= 0 in POP-Q OR Subjective failure through reliable condition-specific quality-of-life questionnaires: A positive response to the question "Do you usually have a bulge or something falling out that you can see or feel in your vaginal area?" (question 3 of the PFDI-20) OR A PGI-I score > 2 OR Need of a new treatment for prolapse (surgical or medical) |
3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04172896 -
Intraperitoneal and Extraperitoneal Uterosacral Ligament Suspensions for Post-Hysterectomy Vaginal Vault Prolapse
|
N/A | |
Completed |
NCT03966469 -
What is the Impact of the Presence of a Support Person on Informed Consent
|
||
Completed |
NCT04882995 -
Effect of Preoperative Fiber on Postoperative Bowel Function
|
N/A | |
Recruiting |
NCT04440475 -
Tap Block vs Conventional Pain Medication for Patients Undergoing Robotic Sacrocolpopexy
|
N/A | |
Not yet recruiting |
NCT06416982 -
Perineal Massage for Pessary Examinations
|
N/A | |
Not yet recruiting |
NCT03527082 -
Women's Knowledge and Attitudes to Use of Mesh in Gynaecological Surgery
|
||
Recruiting |
NCT05633901 -
Impact of Preop Video on Patient Anxiety
|
N/A | |
Recruiting |
NCT05750615 -
What Affects Willingness to Self-manage a Pessary?
|
||
Completed |
NCT03962075 -
Short-term Outcomes of Laparoscopic Repair of Paravaginal Defects
|
N/A |